Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Amble vs LIV by WellNow

Amble
Graded #212

Higher grade

vs+2.8999999999999986
LIV by WellNow
Graded #262

Lower grade

The verdict

Amble takes it — 65.8/100 to 62.9/100.

Amble grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Telehealth weight loss provider offering compounded semaglutide and tiered tirzepatide programs.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueAmble +10
61
51
Dose & formulationLIV by WellNow +9
64
73
Clinical oversightEven
79
79
Labs & monitoringEven
52
52
FulfillmentAmble +18
81
63
Contract termsEven
55
55
Amble · left barLIV by WellNow · right bar

The numbers

MetricAmbleLIV by WellNow
WeighScore65.8/10062.9/100
GradeCC
Scorecard rank#212#262
Semaglutide$179/mo (starting dose, compounded)$279/mo
Tirzepatide$289/mo (starting dose, compounded)Not disclosed
CoverageAll 50 states5 states
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyInjection only
Amble

Graded #212 · C

Strengths

  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access

Where it loses points

  • Limited public information on program details
LIV by WellNow

Graded #262 · C

Strengths

  • Flat $279/month covers medication, supplies, and unlimited virtual visits
  • Backed by established WellNow Urgent Care brand
  • Board-certified online medical providers
  • Same-day approval and monthly home delivery
  • Transparent all-inclusive pricing with no hidden fees

Where it loses points

  • Compounded semaglutide is not FDA-approved or evaluated
  • Only available in five states (IL, IN, MI, NY, PA)
  • No tirzepatide option offered
  • Insurance not accepted for compounded semaglutide

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard